SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-08-030268
Filing Date
2008-05-09
Accepted
2008-05-09 17:28:22
Documents
1
Period of Report
2008-05-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd206029.html 4  
1 FORM 4 rrd206029.xml 4 2897
  Complete submission text file 0001181431-08-030268.txt   4811
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Issuer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address 8054471000
Flanagan Thomas James (Reporting) CIK: 0001376155 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12477 | Film No.: 08819856